Pediatric Zylet Safety and Efficacy Study

• Status: Completed
• Trial end date: 2009-06-01

Summary

A multicenter study to evaluate the safety and efficacy of Zylet compared to vehicle in children aged 0-6 for the management of lid inflammation (chalazion/hordeolum)

• Phase: Phase 4

Details

• Lead Sponsor: Bausch & Lomb Incorporated
• Treatments: Loteprednol Etabonate; Tobramycin